Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01883414 · ClinicalTrials.gov registry record · NA
Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.
A NA study, sponsored by Ulthera.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01883414: Clinical Trial NA study, sponsored by Ulthera.
NCT01883414 is a NA study that was terminated before completion, run by Ulthera. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01883414, a NA study, was terminated before completion, sponsored by Ulthera.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Up to 25 subjects will be enrolled. Enrolled subjects will received on Ulthera® treatment on one half of their surgical scar. Follow up visits will occur at 30, 90 and 180 days after treatment. Study images will be obtained before treatment, immediately after treatment and at each follow-up visit.
Primary Outcome
Masked assessors will compare baseline images to images obtained at the 90 day follow up time point in a blinded fashion.
Interventions
- DEVICE Ultherapy™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-02 |
| Phase | NA |
Why NCT01883414 stopped before completion
NCT01883414 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Ultherapy™ is the first listed.
NCT01883414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01883414 about?
NCT01883414 is a clinical study titled "Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.". Up to 25 subjects will be enrolled. Enrolled subjects will received on Ulthera® treatment on one half of their surgical scar. Follow up visits will occur at 30, 90 and 180 days after treatment. Study images will be obtained before treatment, immediately after treatment and at each follow-up visit.
What is the current status of trial NCT01883414?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2013-06. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01883414?
The interventions under investigation include: Ultherapy™ (DEVICE).
Who is sponsoring clinical trial NCT01883414?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01883414's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia